126 related articles for article (PubMed ID: 38280546)
1. Metabolic reprogramming driven by METTL1-mediated tRNA m7G modification promotes acquired anlotinib resistance in oral squamous cell carcinoma.
Chen J; Zhou Q; Li S; Ling R; Zhao Y; Chen D; Wang A; Cao Y
Transl Res; 2024 Jun; 268():28-39. PubMed ID: 38280546
[TBL] [Abstract][Full Text] [Related]
2. METTL1-Mediated m7G tRNA Modification Promotes Lenvatinib Resistance in Hepatocellular Carcinoma.
Huang M; Long J; Yao Z; Zhao Y; Zhao Y; Liao J; Lei K; Xiao H; Dai Z; Peng S; Lin S; Xu L; Kuang M
Cancer Res; 2023 Jan; 83(1):89-102. PubMed ID: 36102722
[TBL] [Abstract][Full Text] [Related]
3. Aberrant translation regulated by METTL1/WDR4-mediated tRNA N7-methylguanosine modification drives head and neck squamous cell carcinoma progression.
Chen J; Li K; Chen J; Wang X; Ling R; Cheng M; Chen Z; Chen F; He Q; Li S; Zhang C; Jiang Y; Chen Q; Wang A; Chen D
Cancer Commun (Lond); 2022 Mar; 42(3):223-244. PubMed ID: 35179319
[TBL] [Abstract][Full Text] [Related]
4. SOD2 confers anlotinib resistance via regulation of mitochondrial damage in OSCC.
Li S; Cao C; Huang Z; Tang D; Chen J; Wang A; He Q
Oral Dis; 2024 Mar; 30(2):281-291. PubMed ID: 36229195
[TBL] [Abstract][Full Text] [Related]
5. Anlotinib Suppresses Oral Squamous Cell Carcinoma Growth and Metastasis by Targeting the RAS Protein to Inhibit the PI3K/Akt Signalling Pathway.
Lu Y; Lin J; Duan M; Rui Y; Zheng H; Zhu L; Zhu X; Wei J
Anal Cell Pathol (Amst); 2021; 2021():5228713. PubMed ID: 34926131
[TBL] [Abstract][Full Text] [Related]
6. METTL1-mediated tRNA m
Du D; Zhou M; Ju C; Yin J; Wang C; Xu X; Yang Y; Li Y; Cui L; Wang Z; Lei Y; Li H; He F; He J
J Exp Clin Cancer Res; 2024 May; 43(1):154. PubMed ID: 38822363
[TBL] [Abstract][Full Text] [Related]
7. P300/SP1 complex mediating elevated METTL1 regulates CDK14 mRNA stability via internal m7G modification in CRPC.
Zhang M; Kan D; Zhang B; Chen X; Wang C; Chen S; Gao W; Yang Z; Li Y; Chen Y; Zhu S; Wen S; Niu Y; Shang Z
J Exp Clin Cancer Res; 2023 Aug; 42(1):215. PubMed ID: 37599359
[TBL] [Abstract][Full Text] [Related]
8. METTL1 promotes hepatocarcinogenesis via m
Chen Z; Zhu W; Zhu S; Sun K; Liao J; Liu H; Dai Z; Han H; Ren X; Yang Q; Zheng S; Peng B; Peng S; Kuang M; Lin S
Clin Transl Med; 2021 Dec; 11(12):e661. PubMed ID: 34898034
[TBL] [Abstract][Full Text] [Related]
9. Suppressed mitochondrial respiration via NOX5-mediated redox imbalance contributes to the antitumor activity of anlotinib in oral squamous cell carcinoma.
Huang Z; Su Q; Li W; Ren H; Huang H; Wang A
J Genet Genomics; 2021 Jul; 48(7):582-594. PubMed ID: 34373220
[TBL] [Abstract][Full Text] [Related]
10. METTL1/WDR4-mediated tRNA m
Wang Z; Yu P; Zou Y; Ma J; Han H; Wei W; Yang C; Zheng S; Guo S; Wang J; Liu L; Lin S
Oncogene; 2023 Jun; 42(23):1900-1912. PubMed ID: 37185458
[TBL] [Abstract][Full Text] [Related]
11. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
12. N
Chen B; Jiang W; Huang Y; Zhang J; Yu P; Wu L; Peng H
Oncogene; 2022 Apr; 41(15):2239-2253. PubMed ID: 35217794
[TBL] [Abstract][Full Text] [Related]
13. Concurrent use of anlotinib overcomes acquired resistance to EGFR-TKI in patients with advanced EGFR-mutant non-small cell lung cancer.
Zhang C; Cao H; Cui Y; Jin S; Gao W; Huang C; Guo R
Thorac Cancer; 2021 Oct; 12(19):2574-2584. PubMed ID: 34510760
[TBL] [Abstract][Full Text] [Related]
14. N
Han H; Yang C; Ma J; Zhang S; Zheng S; Ling R; Sun K; Guo S; Huang B; Liang Y; Wang L; Chen S; Wang Z; Wei W; Huang Y; Peng H; Jiang YZ; Choe J; Lin S
Nat Commun; 2022 Mar; 13(1):1478. PubMed ID: 35304469
[TBL] [Abstract][Full Text] [Related]
15. WDR4 promotes HCC pathogenesis through N
Dong R; Wang C; Tang B; Cheng Y; Peng X; Yang X; Ni B; Li J
Cell Signal; 2024 Jun; 118():111145. PubMed ID: 38493882
[TBL] [Abstract][Full Text] [Related]
16. Anlotinib can overcome acquired resistance to EGFR-TKIs via FGFR1 signaling in non-small cell lung cancer without harboring EGFR T790M mutation.
Lian Z; Du W; Zhang Y; Fu Y; Liu T; Wang A; Cai T; Zhu J; Zeng Y; Liu Z; Huang JA
Thorac Cancer; 2020 Jul; 11(7):1934-1943. PubMed ID: 32433828
[TBL] [Abstract][Full Text] [Related]
17. tRNA modifying enzymes, NSUN2 and METTL1, determine sensitivity to 5-fluorouracil in HeLa cells.
Okamoto M; Fujiwara M; Hori M; Okada K; Yazama F; Konishi H; Xiao Y; Qi G; Shimamoto F; Ota T; Temme A; Tatsuka M
PLoS Genet; 2014 Sep; 10(9):e1004639. PubMed ID: 25233213
[TBL] [Abstract][Full Text] [Related]
18. Association of cancer metabolism-related proteins with oral carcinogenesis - indications for chemoprevention and metabolic sensitizing of oral squamous cell carcinoma?
Grimm M; Cetindis M; Lehmann M; Biegner T; Munz A; Teriete P; Kraut W; Reinert S
J Transl Med; 2014 Jul; 12():208. PubMed ID: 25048361
[TBL] [Abstract][Full Text] [Related]
19. HIF-1α/METTL1/m
Mi S; Cai S; Xue M; Wu W
Biochem Biophys Res Commun; 2024 Jan; 693():149385. PubMed ID: 38118310
[TBL] [Abstract][Full Text] [Related]
20. METTL1-mediated m
Deng Y; Zhou Z; Ji W; Lin S; Wang M
Stem Cell Res Ther; 2020 Jul; 11(1):306. PubMed ID: 32698871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
